Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
323,226,938
-
Share change
-
+4,087,680
-
Total reported value
-
$12,350,690,605
-
Put/Call ratio
-
38%
-
Price per share
-
$38.21
-
Number of holders
-
767
-
Value change
-
+$152,260,225
-
Number of buys
-
345
-
Number of sells
-
291
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q3 2021
As of 30 Sep 2021 GLAXOSMITHKLINE PLC - ADR (GSK) had 767 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 323,226,938 shares of stock of the company.
Largest 10 holders included Dodge & Cox, Capital International Investors, Fisher Asset Management, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Black Creek Investment Management Inc., RENAISSANCE TECHNOLOGIES LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, STATE STREET CORP, and UBS Group AG.
This table shows 775 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.